These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3024197)

  • 21. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naloxone benzoylhydrazone, a kappa 3 opioid agonist, stimulates food intake in rats.
    Koch JE; Pasternak GW; Arjune D; Bodnar RJ
    Brain Res; 1992 May; 581(2):311-4. PubMed ID: 1327401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK; Penz WP; Walker MJ; Wong TM
    Br J Pharmacol; 1992 Mar; 105(3):521-6. PubMed ID: 1320979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
    Nencini P; Stewart J
    Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of intracerebroventricularly administered mu-, delta- and kappa-opioid agonists on locomotor activity of the guinea pig and the pharmacology of the locomotor response to U50,488H.
    Bot G; Chahl LA; Brent PJ; Johnston PA
    Neuropharmacology; 1992 Sep; 31(9):825-33. PubMed ID: 1359440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
    Castillo R; Kissin I; Bradley EL
    Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidin) cyclohexyl]-benzeneacetamide (U-50,488H), a kappa opioid receptor agonist, on intake of food in food-deprived and non-deprived spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Bhargava HN; Ramarao P; Richter CM; Bieniarz AA
    Neuropharmacology; 1989 Jan; 28(1):63-7. PubMed ID: 2927580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of a selective kappa receptor agonist, U-50, 488H, on methamphetamine-elicited ipsilateral circling behavior in rats with unilateral nigral lesions.
    Ohno M; Yamamoto T; Ueki S
    Psychopharmacology (Berl); 1989; 97(2):219-21. PubMed ID: 2543013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze.
    Privette TH; Terrian DM
    Psychopharmacology (Berl); 1995 Apr; 118(4):444-50. PubMed ID: 7568631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan.
    Barjavel MJ; Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jun; 258(3):173-8. PubMed ID: 8088353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endorphins and food intake: kappa opioid receptor agonists and hyperphagia.
    Cooper SJ; Jackson A; Kirkham TC
    Pharmacol Biochem Behav; 1985 Nov; 23(5):889-901. PubMed ID: 2867562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential opiate influences on food hoarding and intake in the deer mouse, Peromyscus maniculatus.
    Kavaliers M; Hirst M
    Life Sci; 1985 Dec; 37(23):2213-20. PubMed ID: 2999543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of serotonergic mechanisms in the inhibitory effect of U-50,488H on glutamate-induced lethality in mice.
    Kamei J; Igarashi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1992 Mar; 75(3):357-60. PubMed ID: 1509202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C; Milanés MV; Vargas ML
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H; Misawa H; Fukushima N; Takagi H
    Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN; Gulati A; Ramarao P
    J Pharmacol Exp Ther; 1989 Oct; 251(1):21-6. PubMed ID: 2552075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
    Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H
    Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feeding induced by opioid stimulation of the ventral striatum: role of opiate receptor subtypes.
    Bakshi VP; Kelley AE
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1253-60. PubMed ID: 8389860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FMRFamide suppresses kappa opiate induced feeding in the mouse.
    Kavaliers M; Hirst M
    Peptides; 1985; 6(5):847-9. PubMed ID: 3001666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse.
    Mama KR; Pascoe PJ; Steffey EP
    Can J Vet Res; 1993 Apr; 57(2):106-9. PubMed ID: 8490803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.